Stock ESPR ESPERION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Static Chart Esperion Therapeutics, Inc.

Equities

ESPR

US29664W1053

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
2.8 USD +13.36% Intraday chart for Esperion Therapeutics, Inc. +29.63% -6.35%
May. 22 Daiichi Sankyo Europe GmbH and Esperion Therapeutics, Inc. Jointly Announce That European Commission Has Approved the Label Update of Both NILEMDO® (bempedoic acid) and NUSTENDI® (bempedoic acid / ezetimibe fixed-dose combination), as Treatments for Hypercholesterolemia and to Reduce the Risk of Adverse Cardiovascular Events CI
May. 20 Esperion Therapeutics Says Primary Endpoint Achieved in Hypercholesterolemia Treatment Phase 3 Trial; Shares Rise MT
Chart Esperion Therapeutics, Inc.
  1. Stock Market
  2. Equities
  3. ESPR Stock
  4. Charts Esperion Therapeutics, Inc.
  5. Static Chart